University of EdinburghInstitute for Neuroscience and Cardiovascular Research

Research

Diabetes: Drivers & Therapeutics

Revealing new knowledge of beta cell function and insulin action to improve human health

Diabetes: Drivers & Therapeutics

Goals:

  • To identify the molecular mechanisms underpinning beta cell destruction and function.

  • To establish the molecular mechanisms underpinning insulin action and how these mechanisms are dysregulated in physiological and pathological contexts (eg diabetes, obesity and ageing).

  • To leverage this knowledge for improved strategies to prevent and treat Type 1 and Type 2 diabetes, cardiometabolic diseases and other chronic, age-related morbidities.

Projects and Research Groups

Optimising islet engraftment and long-term function using cell therapies and other co-therapies. Studies with stem cell derived islets Correcting the dysregulation of glucagon metabolism in response to hypoglycaemia in T1D. Advancing Understanding of Blood Glucose Control in T1D: A Data Science Approach.

Shareen Forbes ↗

Glucocorticoid-induced insulin resistance in adipose tissue and skeletal muscle.

Mark Nixon ↗

Massive parallel functional scanning of insulin signalling genes. Novel treatments for monogenic extreme insulin resistance. Links between PI 3-Kinase signalling and metabolic syndrome.

Robert Semple ↗